Genetic influence on warfarin dose determination

被引：0
|
作者：
Li, J. X. [1 ]
Kim, M. H. [1 ]
Song, K. [1 ]
机构：
[1] Dong A Univ, Dept Cardiol, Coll Med, Busan, South Korea
来源：
EUROPEAN HEART JOURNAL | 2018年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
P5734
引用
收藏
页码：1214 / 1214
页数：1
相关论文
共 50 条
  • [31] Genetic Associations With Stable Warfarin Dose Requirements in Han Chinese Patients
    Xu, Qingqing
    Zhang, Suli
    Wu, Chaoneng
    Xiong, Yuyu
    Niu, Jiamin
    Li, Fengzhen
    Zhu, Jinhang
    Shen, Lu
    Zhu, Bin
    Xing, Qinghe
    He, Lin
    Chen, Luan
    Li, Mo
    Li, Hua
    Ge, Junbo
    Qin, Shengying
    [J]. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 2021, 78 (01) : 105 - 111
  • [32] Genetic and nongenetic factors associated with warfarin dose requirements in Egyptian patients
    Shahin, Mohamed Hossam A.
    Khalifa, Sherief I.
    Gong, Yan
    Hammad, Lamiaa N.
    Sallam, Mohamed T. H.
    El Shafey, Mostafa
    Ali, Shawky S.
    Mohamed, Mohamed-Eslam F.
    Langaee, Taimour
    Johnson, Julie A.
    [J]. PHARMACOGENETICS AND GENOMICS, 2011, 21 (03): : 130 - 135
  • [33] US FDA approves use of genetic testing to estimate warfarin dose
    [J]. Reactions Weekly, 2007, 1166 (1) : 3 - 3
  • [34] Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese
    Zeng, Wu-Tao
    Xu, Qing
    Li, Cheng-Hsun
    Chen, Wei-Yan
    Sun, Xiu-Ting
    Wang, Xiang
    Yang, Yi-Ying
    Shi, Hui
    Yang, Zhi-Sheng
    [J]. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2016, 72 (11) : 1327 - 1334
  • [35] The effect of genetic and nongenetic factors on warfarin dose variability in Qatari population
    Loulia Bader
    Ahmad Mahfouz
    Mohammed Kasem
    Shaban Mohammed
    Sumayya Alsaadi
    Osama Abdelsamad
    Rasha Elenani
    Ezeldin Soaly
    Abdelnasser Elzouki
    Nasser Rizk
    Sherief Khalifa
    Mohamed H. Shahin
    Larisa H. Cavallari
    Fatima Mraiche
    Hazem Elewa
    [J]. The Pharmacogenomics Journal, 2020, 20 : 277 - 284
  • [36] Predicting Range of Initial Warfarin Dose Based on Pharmacometabolomic and Genetic Inputs
    Huang, Qing
    Cao, Ling
    Luo, Nan
    Qian, Hanyu
    Wei, Meng
    Xue, Ling
    Zhou, Qiang
    Zou, Bingjie
    Tan, Li
    Chu, Yanan
    Ma, Xueping
    Wang, Changtian
    Wu, Haiwei
    Zhang, Lei
    Sun, Lei
    Li, Demin
    Fan, Xialei
    Miao, Liyan
    Zhou, Guohua
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2021, 110 (06) : 1585 - 1594
  • [37] Influence of genetic polymorphisms in cytochrome P450 oxidoreductase on the variability in stable warfarin maintenance dose in Han Chinese
    Wu-Tao Zeng
    Qing Xu
    Cheng-Hsun Li
    Wei-Yan Chen
    Xiu-Ting Sun
    Xiang Wang
    Yi-Ying Yang
    Hui Shi
    Zhi-Sheng Yang
    [J]. European Journal of Clinical Pharmacology, 2016, 72 : 1327 - 1334
  • [38] Influence of Regular Physical Activity on Warfarin Dose and Risk of Hemorrhagic Complications
    Shendre, Aditi
    Beasley, Timothy Mark
    Brown, Todd M.
    Hill, Charles E.
    Arnett, Donna K.
    Limdi, Nita A.
    [J]. PHARMACOTHERAPY, 2014, 34 (06): : 545 - 554
  • [39] Influence of Genotype on Warfarin Maintenance Dose Predictions Produced Using a Bayesian Dose Individualization Tool
    Saffian, Shamin M.
    Duffull, Stephen B.
    Roberts, Rebecca L.
    Tait, Robert C.
    Black, Leanne
    Lund, Kirstin A.
    Thomson, Alison H.
    Wright, Daniel F. B.
    [J]. THERAPEUTIC DRUG MONITORING, 2016, 38 (06) : 677 - 683
  • [40] Influence of the VKORC1 3730 G > A polymorphism on warfarin dose
    Jane Skov
    Else-Marie Bladbjerg
    Jørgen Jespersen
    [J]. European Journal of Clinical Pharmacology, 2013, 69 : 1043 - 1044
12345